Ahmedabad: Allurion, a company dedicated to ending obesity, today here announced launch of the Allurion Swallowable Capsule in India – the only medical weight-loss device fully approved by the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority of India overseen by the Ministry of Health & Family Welfare’s Directorate General of Health Services.

The company officials in their briefing in a press conference said – The Allurion Program is for people who are unable to achieve their weight-loss goals by dieting alone or for those who do not want to, or cannot, undergo invasive surgery or endoscopy. It may also be suitable as a treatment for weight-related co-morbidities including diabetes, infertility, or cardiovascular disease.

The patient swallows the Allurion Swallowable Capsule – a temporary vegan capsule that contains a deflated gastric balloon. Once in the stomach, a healthcare professional uses a catheter to inflate the balloon with 550ml of liquid – no surgery, endoscopy, or anesthesia is required. A simple X-ray is used to ensure the balloon is in the right position. After placement, the balloon – roughly the size of a grapefruit – takes up space in the patient’s stomach, creating a feeling of fullness and reducing food intake. The balloon reduces feelings of hunger, and in approximately 16 weeks, it automatically deflates and passes out of the body naturally.

“As someone of Indian origin, India is a special market for Allurion. It is part of my mission to bring our revolutionary technology to India to help end obesity and diabetes,” says Dr. Shantanu Gaur, Founder, and CEO of Allurion.

Allurion Program is also planning Allurion’s Virtual Care Suite, which will integrate the Allurion Mobile App, Connected Scale, and Health Tracker into a single “digital umbrella” to provide remote patient monitoring, telehealth, and secure messaging with the care team. The software platform is powered by artificial intelligence and machine learning to allow care teams to interact with their patients – and their data.

Dr. Mohit Bhandari of Mohak Bariatrics is a bariatric and endoscopic weight-loss surgeon, and a pioneer in offering the Allurion Program in India. “Obesity is on the rise in India with three out of every four urban Indians overweight. As one of the most experienced bariatric surgeons in the Asia Pacific region with 17,000 bariatric surgeries performed to date,” he says.
Allurion launches its weight management solution in India: the Allurion Swallowable Capsule, backed by the comprehensive Allurion Program.

Allurion Program includes

– The Allurion Swallowable Capsule – the procedure-less gastric balloon for weight loss.
– The Allurion Virtual Care Suite (VCS), powered by the Allurion Iris AI platform and featuring the Allurion Mobile App, Connected Scale, and Health Tracker to provide real-time insights to both patients and healthcare practitioners